Topiramate in benzodiazepine withdrawal

Human Psychopharmacology

Volumn 18, Issue 5, 2003, Pages 375-377

  Cheseaux, Michel ^a   Monnat, Martine ^a   Zullino, Daniele F ^b  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

Author keywords

AMPA receptor; Anticonvulsant; Benzodiazepine withdrawal; Detoxification; Substance abuse

Indexed keywords

AMPA RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CANNABIS; COCAINE; METHADONE; METOCLOPRAMIDE; MIDAZOLAM; OPIATE; TOPIRAMATE; TRIMIPRAMINE; ZOPICLONE;

ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR DISORDER; CANNABIS ADDICTION; CASE REPORT; CIGARETTE SMOKING; COCAINE DEPENDENCE; DIAPHORESIS; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFORMED CONSENT; INSOMNIA; IRRITABILITY; LOCUS CERULEUS; MALE; METHADONE TREATMENT; MODULATION; MUSCLE CRAMP; NAUSEA AND VOMITING; NERVE CELL STIMULATION; NORADRENERGIC NERVE; OPIATE ADDICTION; PRIORITY JOURNAL; REHABILITATION MEDICINE; RELAPSE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; ANTICONVULSANTS; BENZODIAZEPINES; FRUCTOSE; HUMANS; MALE; RECEPTORS, AMPA; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0042813502     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.497     Document Type: Article

References (15)

1. Klein E, Uhde TW, Post RM. 1986. Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. Am J Psychiatry 143: 235-236.
2. Krenz SL, Zimmermann G, Pin M, Kolly S, Besson J, Zullino D. 2002. Topiramate in multidrug withdrawal-comparison with clonidine. Eur Psychiatry: Assoc Eur Psychiatrists 17(Suppl. 1): 213-214.
3. Langtry HD, Gillis JC, Davis R. 1997. Topiramate - A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 54: 752-773.
4. Lichtigfeld FJ, Gillman MA. 1991. Combination therapy with carbamazepine/benzodiazepine for polydrug analgesic/depressant withdrawal. J Subst Abuse Treat 8: 293-295.
5. Martijena ID, Lacerra C, Molina VA. 1997. Carbamazepine normalizes the altered behavioral and neurochemical response to stress in benzodiazepine-withdrawn rats. Eur J Pharmacol 330: 101-108.
6. Nestler EJ. 2001. Neurobiology: total recall-the memory of addiction. Science 292: 2266-2267.
7. Rasmussen K. 1995. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology 13: 295-300.
8. Rickels K, DeMartinis N, Rynn M, Mandos L. 1999a. Pharmacologic strategies for discontinuing benzodiazepine treatment. J Clin Psychopharmacol 19(Suppl.): 16S.
9. Rickels K, Schweizer E, Garcia EF, Case G, DeMartinis N, Greenblatt D. 1999b. Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome. Psychopharmacology (Berl) 141: 1-5.
10. Ries RK, Roy-Byrne PP, Ward NG, Neppe V, Cullison S. 1989. Carbamazepine treatment for benzodiazepine withdrawal. Am J Psychiatry 146: 536-537.
11. Roy-Byrne PP, Sullivan MD, Cowley DS, Ries RK. 1993. Adjunctive treatment of benzodiazepine discontinuation syndromes: a review. J Psychiatr Res 27(Suppl. 1): 143-153.
12. Schweizer E, Rickels K. 1998. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand 98: 95-101.
13. Schweizer E, Rickels K, Case WG, Greenblatt DJ. 1991. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Arch Gen Psychiatry 48: 448-452.
14. Vgontzas AN, Kales A, Bixler EO. 1995. Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics. [Review] [196 refs]. Pharmacology 51: 205-223.
15. Zullino DF, Kolly S, Krenz S, Zimmermann G, Besson J. 2002. Les Nouveaux Médicaments dans la Prise en Charge des Addictions, Guffens JM (ed.). Frison-Roche. Colloques THS 5; Paris, 260-265.